There are 2789 resources available
368P - Characteristics of deleterious germline mutations in glioma patients
Presenter: Gousiyi Wang
Session: ePoster Display
369P - Characterization of the inflammatory tumor microenvironment composition in brain metastases after failure of immune checkpoint inhibitor therapy
Presenter: Angelika M. Starzer
Session: ePoster Display
370P - Prospective study of apatinib combined with whole brain radiation therapy and simultaneous integrated boost for brain metastases from lung cancer
Presenter: Guang Han
Session: ePoster Display
371P - Low-dose bevacizumab for the treatment of focal post-radiation necrosis of the brain
Presenter: Jens Tijtgat
Session: ePoster Display
306P - Real-world study of treatments received and treatment satisfaction among HER2- advanced breast cancer (ABC) patients in EU3 and US
Presenter: Katie Lewis
Session: ePoster Display
307P - Overall survival in metastatic breast cancer patients according to different follow up strategies for early breast cancer
Presenter: Eva Blondeaux
Session: ePoster Display
308P - FDG-PET/CT versus CE-CT for response monitoring in metastatic breast cancer: A prospective comparative study
Presenter: Marianne Vogsen
Session: ePoster Display
309P - Antineoplastic (ANP) therapies (Tx) after alpelisib (ALP) or placebo (PBO) + fulvestrant (FUL) in patients (Pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), PIK3CA-mutated (Mut) advanced breast cancer (ABC): An analysis from SOLAR-1
Presenter: Fabrice André
Session: ePoster Display
310P - Substantial reduction in the percentage of metastatic breast cancer (MBC) which is HER-2 positive (HER-2+) over two decades: Sequential cohort analysis from the 1000 patient HER-2 study
Presenter: Jose Javier Berenguer-pina
Session: ePoster Display
423P - From clinical trial to bedside: Triplet chemotherapy (FOLFOXIRI-B) in metastatic colorectal cancer
Presenter: Guus Bol
Session: ePoster Display